MARCELLUSI, ANDREA
MARCELLUSI, ANDREA
Dipartimento di Scienze Farmaceutiche
Oxygen-Enriched Olive-Oil Dressing in Moderate-Degree Pediatric Burns: Impact on Care and Budget over a 4-Year Period in a Tertiary Children’s Hospital
2026 S. Borghetti, U.M. Pierucci, C. Palladino, S. Vimercati, F. Selmin, A. Marcellusi, G. Tosi, A. Musitelli, E. Zoia, I. Paraboschi, G. Pelizzo
Evoluzione terapeutica: tradurre l'innovazione farmacologica in benefici tangibili per le persone con emofilia A. Una prospettiva multi-stakeholder
2025 M.N.D. Di Minno, V. Drago, A. Marcellusi, S. Amato, C. Mattia, E.F. Grazzi, F. Drago, D. Fornasari
Cost-Estimation Model of Prevented Recurrences with Atezolizumab in Early Non-Small-Cell Lung Cancer in Italy
2025 A. Marcellusi, M. Belfiore, R. Tempre, M. Buonfiglio, A. Russo
Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy
2025 A. Marcellusi, C. Bini, B. Muzii, S. Soudani, A. Kieffer, M. Beuvelet, E. Bozzola, F. Midulla, E. Baraldi, P. Bonanni, S. Boccalini, L. Orfeo
The economic benefit of implementing assisted reproductive technology within a national health system: insights from the Italian model
2025 A. Marcellusi, M. Scortichini, G. Guarnotta, M. Connolly, A. Busnelli
Transforming PAH care in Italy: a clinical and economic evaluation of sotatercept add-on therapy.
2025 M. Paoletti, A. Marcellusi, D. Di Laura, R. Van Den Puttelaar, G. Van De Wetering, M. Jootun
Long-Term Effects of Direct-Acting Antivirals on Hepatitis C: Trends in Liver Disease-Related Hospitalisations in Italy
2025 F. Mennini, P. Sciattella, C. Simonelli, A. Marcellusi, S. Rosato, L. Kondili
Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027
2025 A. Marcellusi, D. Cazzato, G. Guarnotta, A. Aiello, M. Bonfanti, R. Bitonti, M. Guardigni, C. Lucchetti, F. Luccini, P. Canonico, C. Jommi
Cost-effectiveness of cenobamate as a therapeutic alternative for the treatment of focal epilepsy in adults with inadequate seizure control
2025 M. Paoletti, A. Ragonese, L. Budassi, A. Marcellusi
Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes
2025 J. Lazarus, L. Agirre-Garrido, L. Díaz, P. Danpanichkul, S. Kivuyo, L. Kondili, H. Hagström, H. Takahashi, J. Pericàs, C. Spearman, C. Oliveira, C. Villela-Nogueira, J. Schattenberg, E. Toresson Grip, N. Alkhouri, A. Marcellusi, H. Mark, A. Allen, N. Carvalho Leite, H. Al-Omar, S. Alqahtani, N. Brachowicz
Analisi di costo-efficacia di Brentuximab Vedotin + CHP in pazienti con linfoma anaplastico a grandi cellule sistemico [Cost-effectiveness of Brentuximab Vedotin plus chemotherapy as frontline treatment of systemic anaplastic large cell lymphoma in Italy
2025 A. Marcellusi, C. Bini, L. Fioravanti, S. Ripoli, P. Morelli
Cost-Effectiveness Analysis of Nirsevimab for the Prevention of Respiratory Syncytial Virus among Italian Infants.
2025 C. Bini, A. Marcellusi, D. Cazzato, B. Muzii, S. Soudani, E. Bozzola, F. Midulla, E. Baraldi, P. Bonanni, S. Boccalini, L. Orfeo
Burden of disease of Alzheimer disease in Italy: a real-world data analysis
2025 F. Mennini, P. Sciattella, M. Scortichini, R. Migliorini, M. Trabucco Aurilio, A. Marcellusi, A. Bianchetti
Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?
2025 C. Jommi, M. Bonfanti, M. Guardigni, A. Aiello, A. Marcellusi, P. Canonico, F. Luccini, C. Lucchetti
Burden of Disease of Breast Cancer in Italy: A Real-World Data Analysis.
2025 F. Mennini, A. Marcellusi, P. Sciattella, M. Scortichini, A. Ragonese, F. Cattel, R. D'Antona, L. Del Mastro, S. Gori, G. Perrone, R. Migliorini, M. Trabucco Aurilio
Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy.
2024 M. Paoletti, C. Bini, A. Marcellusi, F. Mennini
The economic burden of asthma in Italy: evaluating the potential impact of different treatments in adult patients with severe eosinophilic asthma
2024 M. Scortichini, F. Mennini, A. Marcellusi, M. Paoletti, C. Tomino, P. Sciattella
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy.
2024 G. Ghetti, F. Mennini, A. Marcellusi, M. Bischof, G. Pistillo, M. Pane
Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis
2024 A. Marcellusi, F. Mennini, M. Andreoni, L. Kondili
An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy
2024 F. Mennini, P. Sciattella, A. Marcellusi, F. Bartolini, F. Bernardi, F. Levrat-Guillen, M. Cozzolino, M. Di Gennaro, R. Giordana, M. Giustozzi, U. Trama